Fairfield, Bush & Co’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-600
Closed -$5.49K 363
2023
Q4
$5.49K Buy
+600
New +$4.14K ﹤0.01% 344
2023
Q3
Sell
-600
Closed -$4.84K 377
2023
Q2
$4.84K Buy
+600
New +$4.42K ﹤0.01% 375
2022
Q3
Sell
-500
Closed -$2K 350
2022
Q2
$2K Buy
+500
New +$3.18K ﹤0.01% 399

Other funds holding OSCR

Fairfield, Bush & Co's OSCR Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Oscar Health (OSCR) in Q1 2024, closing a stake of 600 shares — an estimated $5.49K sold.

Fairfield, Bush & Co first reported a position in OSCR in Q2 2022 and held it in 3 quarters. The position peaked at $5.49K in Q4 2023. 220 funds tracked by Wall St. Rank hold OSCR as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Oscar Health position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 600 Oscar Health shares in Q1 2024, an estimated $5.49K.
  • Fairfield, Bush & Co first reported a position in Oscar Health in Q2 2022 and held it in 3 quarters.
  • Fairfield, Bush & Co's Oscar Health position peaked at $5.49K in Q4 2023.
  • 220 funds tracked by Wall St. Rank held Oscar Health as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.